Physician profile
Michael Ragen
NPI 1326230822
$969.38
in general payments reported to CMS, 2019-2025
10 companies · $34.54 in 2025
The $34.54 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $210 · 2020: $67.40 · 2021: $44.64 · 2022: $369 · 2023: $243 · 2025: $34.54.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $278.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $277.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $273.92 | 2022-2023 | |
| Glaukos Corporation | $154.43 | 2021-2022 | |
| Biotissue Holdings INC. | $143.55 | 2023 | |
| Johnson & Johnson Surgical Vision, INC. | $140.60 | 2019-2023 | Tecnis Iol |
| Alcon Vision LLC | $82.00 | 2022-2025 | Unity, Clareon, Argos |
| Sun Pharmaceutical Industries INC. | $51.08 | 2019-2020 | |
| Allergan, INC. | $41.65 | 2019-2021 | |
| Carl Zeiss Meditec Ag | $38.80 | 2020 | |
| Optos, INC. | $27.25 | 2019 | |
| Novartis Pharmaceuticals Corporation | $16.10 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Ragen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.